172 related articles for article (PubMed ID: 1457622)
21. [Brain mapping for discriminating age related changes from dementia].
Szelies B
Nervenarzt; 1992 Oct; 63(10):609-18. PubMed ID: 1436251
[TBL] [Abstract][Full Text] [Related]
22. Denbufylline in dementia: a double-blind controlled study.
Treves TA; Korczyn AD
Dement Geriatr Cogn Disord; 1999; 10(6):505-10. PubMed ID: 10559567
[TBL] [Abstract][Full Text] [Related]
23. [EEG changes in senile dementia of the Alzheimer type].
Logar C; Grabmair W; Schneider G; Lechner H
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1987 Dec; 18(4):214-7. PubMed ID: 3123199
[TBL] [Abstract][Full Text] [Related]
24. Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.
Saletu B; Anderer P; Semlitsch HV
Dement Geriatr Cogn Disord; 1997; 8 Suppl 1():12-21. PubMed ID: 9205834
[No Abstract] [Full Text] [Related]
25. Event-related potentials in senile dementia of Alzheimer's type, multiinfarct dementia and Parkinson's disease.
Hanafusa H; Motomura N; Fukai M
Jpn J Psychiatry Neurol; 1991 Sep; 45(3):667-70. PubMed ID: 1800814
[TBL] [Abstract][Full Text] [Related]
26. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT).
Fünfgeld EW; Baggen M; Nedwidek P; Richstein B; Mistlberger G
Prog Clin Biol Res; 1989; 317():1235-46. PubMed ID: 2690093
[TBL] [Abstract][Full Text] [Related]
27. EEG mapping--a new way of monitoring in epilepsy.
Logar C; Walzl B; Lechner H
Eur Neurol; 1994; 34 Suppl 1():24-8. PubMed ID: 8001605
[TBL] [Abstract][Full Text] [Related]
28. Reduced EEG coherence in dementia: state or trait marker?
Dunkin JJ; Leuchter AF; Newton TF; Cook IA
Biol Psychiatry; 1994 Jun; 35(11):870-9. PubMed ID: 8054410
[TBL] [Abstract][Full Text] [Related]
29. Quantitative EEG during a double-blind trial of THA and lecithin in patients with Alzheimer's disease.
Perryman KM; Fitten LJ
J Geriatr Psychiatry Neurol; 1991; 4(3):127-33. PubMed ID: 1953964
[TBL] [Abstract][Full Text] [Related]
30. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
31. EEG spectral analysis in delirium.
Koponen H; Partanen J; Pääkkönen A; Mattila E; Riekkinen PJ
J Neurol Neurosurg Psychiatry; 1989 Aug; 52(8):980-5. PubMed ID: 2795067
[TBL] [Abstract][Full Text] [Related]
32. European Pentoxifylline Multi-Infarct Dementia Study.
Eur Neurol; 1996; 36(5):315-21. PubMed ID: 8864715
[TBL] [Abstract][Full Text] [Related]
33. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
[TBL] [Abstract][Full Text] [Related]
34. Computerized EEG in schizophrenic patients.
Miyauchi T; Tanaka K; Hagimoto H; Miura T; Kishimoto H; Matsushita M
Biol Psychiatry; 1990 Sep; 28(6):488-94. PubMed ID: 2223918
[TBL] [Abstract][Full Text] [Related]
35. Staging in dementia of the Alzheimer type: topography of electrical brain activity reflects the severity of the disease.
Ihl R; Maurer K; Dierks T; Frlich L; Perisic I
Psychiatry Res; 1989 Sep; 29(3):399-401. PubMed ID: 2608801
[No Abstract] [Full Text] [Related]
36. Brain electrical activity mapping in different stages of SDAT.
Fuenfgeld EW
Psychiatry Res; 1989 Sep; 29(3):411-2. PubMed ID: 2692057
[No Abstract] [Full Text] [Related]
37. Topographic EEG changes with normal aging and SDAT.
Breslau J; Starr A; Sicotte N; Higa J; Buchsbaum MS
Electroencephalogr Clin Neurophysiol; 1989 Apr; 72(4):281-9. PubMed ID: 2467793
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT).
Rüther E; Ritter R; Apecechea M; Freytag S; Windisch M
Pharmacopsychiatry; 1994 Jan; 27(1):32-40. PubMed ID: 8159781
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of organic brain syndrome with nicergoline given once a day].
Ladurner G; Erhart P; Erhart C; Scheiber V
Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
[TBL] [Abstract][Full Text] [Related]
40. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study.
Grossmann WM; Standl A; May U; van Laak HH; Hirche H
Pharmacopsychiatry; 1990 Nov; 23(6):265-73. PubMed ID: 2284328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
